Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

3,710.00p
   
  • Change Today:
    -40.00p
  • 52 Week High: 5,060.00
  • 52 Week Low: 3,225.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 1,809
  • Market Cap: £193.65m

Latest Deals

Traded Action Notifier PriceAmountValue
30-Oct-24 Buy Bruce Hiscock 3,330.00p 300 £9,990.00

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
30-Oct-24 Buy Bruce Hiscock 3,330.00p 300 £9,990.00

Director Shareholdings

Notifier Holding Value*
Peter John Harrison 297,088 £11,021,965
Ian James Nicholson 13,000 £482,300
Bruce Hiscock 1,089 £40,402

Major Shareholders

Notifier** Holding Value*
Rathbones Investment Management Ltd 5,219,656 £193,649,238
Castlefield Fund Partners Limited 985,000 £36,543,500
SANFORD DELAND ASSET MANAGEMENT LTD 885,000 £32,833,500
SANFORD DELAND ASSET MANAGEMENT LTD 619,500 £22,983,450
Gresham House Asset Management Limited 577,782 £21,435,712
Miton Group plc 508,135 £18,851,808
The Diverse Income Trust plc 302,300 £11,215,330
Schroders plc 284,795 £10,565,894
Wasatch Advisors, Inc. 265,000 £9,831,500
Canaccord Genuity Group Inc 259,940 £9,643,774
Adrian Williams 253,372 £9,400,101

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 3,710.00p
Change Today -40.00p
% Change -1.07 %
52 Week High 5,060.00
52 Week Low 3,225.00
Volume 1,809
Shares Issued 5.22m
Market Cap £193.65m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
67.17% below the market average67.17% below the market average67.17% below the market average67.17% below the market average67.17% below the market average
36.00% above the sector average36.00% above the sector average36.00% above the sector average36.00% above the sector average36.00% above the sector average
Price Trend
14.7% below the market average14.7% below the market average14.7% below the market average14.7% below the market average14.7% below the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Income
2.30% above the market average2.30% above the market average2.30% above the market average2.30% above the market average2.30% above the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average
Growth
43.01% below the market average43.01% below the market average43.01% below the market average43.01% below the market average43.01% below the market average
17.65% below the sector average17.65% below the sector average17.65% below the sector average17.65% below the sector average17.65% below the sector average

Bioventix Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 07-Nov-24 11-Apr-24
Paid 21-Nov-24 26-Apr-24
Amount 87.00p 68.00p

Trades for 21-Nov-2024

Time Volume / Share Price
16:24 0 @ 3,700.00p
16:24 1 @ 3,700.00p
15:46 12 @ 3,794.00p
15:23 24 @ 3,746.00p
15:01 144 @ 3,794.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page